Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Samsung Biologics faces suit from Amgen over bone biosimilars
Americas
Samsung Biologics faces suit from Amgen over bone biosimilars
Amgen alleges infringement by proposed biosimilar versions of Prolia and XGEVA | Complaint accuses Samsung of failing to fully disclose biosimilar application and seeks injunction on bone-treatment products.   15 August 2024
Morrison Foerster expands with trio of litigators
Careers
Morrison Foerster expands with trio of litigators
The firm adds three partners to its New York office | Expansion brings a combined 60 years of experience | Hires experienced in high-stakes patent disputes involving biologics, small-molecule drugs, and medical devices.   8 August 2024
Court halts Oura smart ring dispute
Americas
Court halts Oura smart ring dispute
District court partially grants Ultrahuman Healthcare's motion to stay patent litigation with Oura Health, pending an ITC investigation | Court's order pauses several patent claims | Decision allows Oura's copyright allegations to proceed independently.   6 August 2024
Americas
Sanofi subsidiary sues Sarepta over gene therapy
Massachusetts biotech giants clash as Genzyme alleges Sarepta's Elevidys infringes on key gene therapy patents | Despite the dispute, Elevidys $200M in sales and recent FDA approvals show success.   30 July 2024
Europe
UKIPO launches ‘revolutionary’ patent filing and AI tool
First patent filed using the new digital One IPO service | AI-powered internal tool to speed up the application process | Set for public launch in 2025 with a promise to “revolutionise” patent management.   18 July 2024
Americas
USPTO clarifies AI's role in patent eligibility
Guidance says use of AI in inventing does not affect how patent claims are assessed for eligibility | Emphasis placed on evaluating inventions themselves rather than the method of creation | Updates include new examples to assist examiners in evaluating AI-related patent claims.   18 July 2024
Unified Patent Court
Sanofi and Regeneron triumph in UPC decision against Amgen
UPC’s Munich Central Division revokes Amgen's patent | Decision stems from a revocation action initiated by Sanofi last year | Court's ruling focused on interpretations of patent claims and principles of inventive step.   16 July 2024
Careers
Polsinelli expands Hatch-Waxman and litigation practices
Firm adds new chair of Hatch-Waxman & Biologics Practice is an FDA and pharma litigation expert who will ‘provide clarity in an uncertain post-Chevron world’ | Shareholder brings extensive trial and appellate experience in automotive industry.   16 July 2024
Pharma
Novo Nordisk’s uphill battle in the counterfeit weight loss craze
As the popularity of weight-loss drugs like Ozempic soars, the Danish company has to manage seasoned criminals and international investigations to get results, finds Marisa Woutersen.   12 July 2024
Unified Patent Court
UPC’s second infringement decision revokes patent in Europe
Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | DexCom and Abbott dispute over technology for remotely monitoring blood glucose levels in diabetes patients.   9 July 2024

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.